Stemline Therapeutics, Inc. Stock
Equities
US85858C1071
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
David Gionco
DFI | Director of Finance/CFO | 63 | 14-01-15 |
Jeffrey Levitt
CMP | Compliance Officer | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.01% | 21.66B | |
-18.35% | 20.77B | |
-8.98% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |